Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial

Haematologica

Volumn 92, Issue 3, 2007, Pages 342-348

  Vitale, Antonella ^a   Guarini, Anna ^a   Ariola, Cristina ^a   Meloni, Giovanna ^a   Perbellini, Omar ^b   Pizzuti, Michele ^c   De Gregoris, Cinzia ^d   Mettivier, Vincenzo ^e   Pastorini, Alessandro ^f   Pizzolo, Giovanni ^b   Vignetti, Marco ^a   Mandelli, Franco ^g   Foà, Robin ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c SAN CARLO HOSPITAL   (Italy)

^d Ospedale di Montefiascone   (Italy)

^e CARDARELLI HOSPITAL   (Italy)

^f Ospedale E Morelli   (Italy)

^g GIMEMA Foundation   (Italy)

Author keywords

Adult ALL; Myeloid antigen; Prognosis

Indexed keywords

ASPARAGINASE; CD33 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; TUMOR ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BLAST CELL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL COUNT; CELL LINEAGE; CLINICAL FEATURE; CLINICAL PROTOCOL; COHORT ANALYSIS; CORRELATION ANALYSIS; CYTOGENETICS; DISEASE FREE SURVIVAL; FEMALE; GENETIC RISK; HEMATOLOGICAL PARAMETERS; HIGH RISK PATIENT; HUMAN; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL PARAMETERS; OVERALL SURVIVAL; PROGNOSIS; SURVIVAL TIME; T LYMPHOCYTE; THROMBOCYTE COUNT; TREATMENT RESPONSE; ACUTE LYMPHOCYTIC LEUKEMIA; ADJUVANT THERAPY; ADOLESCENT; AGED; B CELL LEUKEMIA; BIOSYNTHESIS; BLOOD; BLOOD CELL COUNT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG RESISTANCE; GENETICS; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIDRUG RESISTANCE; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SKULL IRRADIATION; STATISTICS; T CELL LEUKEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; CELL LINEAGE; COHORT STUDIES; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; LEUKEMIA, T-CELL, ACUTE; MALE; MIDDLE AGED; MULTICENTER STUDIES; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; REMISSION INDUCTION;

EID: 34247631244     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10385     Document Type: Article

References (18)

1. Drexler HG, Thiel E and Ludwig WD. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 1991;5:637-45.
2. Boldt DH, Kopecky KJ, Head D, Gehly G, Radich JP, and Appelbaum FR. Expression of myeloid antigen by blast cell in acute lymphoblastic leukemia of adults. The South West Oncology Group experience. Leukemia 1994;8:2118-26.
3. Preti HA, Huh YO, O'Brien SM, Andreeff M, Pierce ST, Keating M and Kantarjian M. Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis. Cancer 1995;76:1564-70.
4. Sobol RE, Mick R, Royston I, Davey FR, Ellison RR, Newman R, et al. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 1987;316:1111-17.
5. Urbano-Ispizua A, Matutes E, Villamor N, Ribera JM, Feliu E, Montserrat E, et al. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. Br J Haematol 1990;75:202-7.
6. Guyotat D, Campos L, Shi ZH, Charrin C, Treille D, Magaud JP and Fiere D. Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia 1990;4:664-6.
7. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, et al. A five drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 1995; 85:2025-37.
8. Czuczman MS, Dodge RK, Stewart CC, Frankel SR, Powell BL, Szatrowski TP, et al. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B. Blood 1999; 93:3931-33.
9. Todeschini G, Tecchio C, Meneghini V, Pizzolo G, Zanotti R, Ricetti MM, et al. Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin. Leukemia 1998;12:144-9.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR and Sultan C. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 1981; 47:553-61.
11. Bene MC, Castoldi G, Knapp W, Ludwing WD, Matutes E, Orfao A and van't Veer MB. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783-86.
12. ISCN: An International System for Human Cytogenetic Nomenclature (ed. by F Mitelman), Karger, S, Basel: Switzerland. p. 1995.
13. Van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:1901-28.
14. Tafuri A, Gregori C, Petrucci MT, Ricciardi MR, Mancini M, Cimino G, et al. MDR1 protein expression is an independent predictor factor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood 2002;100:974-81.
15. Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988;71:123-31.
16. Hoelzer D, Gokbuget N. Recent approaches in acute lymphoblastic leukemia in adults. Crit Rev Oncol/Hematol 2000; 36:49-58.
17. Bassan R, Gatta G, Tondini C and Willemze R. Adult acute lymphoblastic leukaemia. Crit Rev Oncol/Hematol 2004;50:223-261.
18. Vitale A, Guarini A, Ariola C, Mancini M, Mecucci C, Cuneo A, et al. Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL0496 protocol. Blood 2006;107:473-9.